These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

126 related items for PubMed ID: 1805729

  • 1. Influence of iron chelators, 1,2-dialkyl-3-hydroxypyridin-4-ones, on the lipid peroxidation and glutathione level in the liver of mice.
    Eybl V, Caisová D, Koutenský J, Kontoghiorghes GJ.
    Arch Toxicol Suppl; 1991; 14():185-7. PubMed ID: 1805729
    [No Abstract] [Full Text] [Related]

  • 2. Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: comparison of their mechanism of protection with that of desferrioxamine.
    Morel I, Cillard J, Lescoat G, Sergent O, Pasdeloup N, Ocaktan AZ, Abdallah MA, Brissot P, Cillard P.
    Free Radic Biol Med; 1992 Nov; 13(5):499-508. PubMed ID: 1334028
    [Abstract] [Full Text] [Related]

  • 3. The influence of deferiprone (L1) and deferoxamine on iron and essential element tissue level and parameters of oxidative status in dietary iron-loaded mice.
    Eybl V, Kotyzová D, Kolek M, Koutenský J, Nielsen P.
    Toxicol Lett; 2002 Mar 10; 128(1-3):169-75. PubMed ID: 11869827
    [Abstract] [Full Text] [Related]

  • 4. Iron mobilization from myocardial cells by 3-hydroxypyridin-4-one chelators: studies in rat heart cells in culture.
    Hershko C, Link G, Pinson A, Peter HH, Dobbin P, Hider RC.
    Blood; 1991 May 01; 77(9):2049-53. PubMed ID: 2018841
    [Abstract] [Full Text] [Related]

  • 5. Inhibition of iron toxicity in rat and human hepatocyte cultures by the hydroxypyridin-4-ones CP20 and CP94.
    Chenoufi N, Hubert N, Loréal O, Morel I, Pasdeloup N, Cillard J, Brissot P, Lescoat G.
    J Hepatol; 1995 Aug 01; 23(2):166-73. PubMed ID: 7499788
    [Abstract] [Full Text] [Related]

  • 6. Origin and fate of iron mobilized by the 3-hydroxypyridin-4-one oral chelators: studies in hypertransfused rats by selective radioiron probes of reticuloendothelial and hepatocellular iron stores.
    Zevin S, Link G, Grady RW, Hider RC, Peter HH, Hershko C.
    Blood; 1992 Jan 01; 79(1):248-53. PubMed ID: 1728313
    [Abstract] [Full Text] [Related]

  • 7. Glutathione depletion increases nitric oxide-induced oxidative stress in primary rat hepatocyte cultures: involvement of low-molecular-weight iron.
    Sinbandhit-Tricot S, Cillard J, Chevanne M, Morel I, Cillard P, Sergent O.
    Free Radic Biol Med; 2003 May 15; 34(10):1283-94. PubMed ID: 12726916
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. The oral iron chelator, 1,2-dimethyl-3-hydroxypyrid-4-one reduces hepatic-free iron, lipid peroxidation and fat accumulation in chronically ethanol-fed rats.
    Sadrzadeh SM, Nanji AA, Price PL.
    J Pharmacol Exp Ther; 1994 May 15; 269(2):632-6. PubMed ID: 8182529
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Green tea extract modulates oxidative tissue injury in beta-thalassemic mice by chelation of redox iron and inhibition of lipid peroxidation.
    Koonyosying P, Kongkarnka S, Uthaipibull C, Svasti S, Fucharoen S, Srichairatanakool S.
    Biomed Pharmacother; 2018 Dec 15; 108():1694-1702. PubMed ID: 30372872
    [Abstract] [Full Text] [Related]

  • 12. Design, synthesis and evaluation of N-basic substituted 3-hydroxypyridin-4-ones: orally active iron chelators with lysosomotrophic potential.
    Liu ZD, Khodr HH, Lu SL, Hider RC.
    J Pharm Pharmacol; 2000 Mar 15; 52(3):263-72. PubMed ID: 10757413
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Effects of green tea on iron accumulation and oxidative stress in livers of iron-challenged thalassemic mice.
    Saewong T, Ounjaijean S, Mundee Y, Pattanapanyasat K, Fucharoen S, Porter JB, Srichairatanakool S.
    Med Chem; 2010 Mar 15; 6(2):57-64. PubMed ID: 20218965
    [Abstract] [Full Text] [Related]

  • 16. Effect of oral iron chelator L1 on iron absorption in man.
    Dresow B, Fischer R, Nielsen P, Gabbe EE, Piga A.
    Ann N Y Acad Sci; 1998 Jun 30; 850():466-8. PubMed ID: 9668586
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. The development of hydroxypyridin-4-ones as orally active iron chelators.
    Hider RC, Singh S, Porter JB, Huehns ER.
    Ann N Y Acad Sci; 1990 Jun 30; 612():327-38. PubMed ID: 2291561
    [No Abstract] [Full Text] [Related]

  • 20. Iron chelation studies using desferrioxamine and the potential oral chelator, 1,2-dimethyl-3-hydroxypyrid-4-one, in normal and iron loaded rats.
    Kontoghiorghes GJ, Sheppard L, Hoffbrand AV, Charalambous J, Tikerpae J, Pippard MJ.
    J Clin Pathol; 1987 Apr 30; 40(4):404-8. PubMed ID: 3584483
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.